Literature DB >> 14377275

Use of reserpine in a neuropsychiatric hospital.

N S KLINE, A M STANLEY.   

Abstract

Entities:  

Keywords:  MENTAL DISORDERS/therapy; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh：

Substances：

Year:  1955        PMID： 14377275     DOI： 10.1111/j.1749-6632.1955.tb42454.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

1.  Experiments on the site of action of tubocurarine when applied via the cerebral ventricles.

Authors:  W FELDBERG; J MALCOLM
Journal:  J Physiol       Date:  1959-12       Impact factor: 5.182

2.  Parkinsonism-physiology and pharmacology.

Authors:  D B Calne
Journal:  Br Med J       Date:  1971-09-18

Review 3.  Measuring the costs of schizophrenia. Implications for the post-institutional era in the US.

Authors:  K G Terkelsen; A Menikoff
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

4.  The effects of reserpine on motor activity and pallidal discharge in monkeys: implications for the genesis of akinesia.

Authors:  R Iansek
Journal:  J Physiol       Date:  1980-04       Impact factor: 5.182

5.  [The Rauwolfia alkaloid, reserpine (serpasil) in psychiatry].

Authors:  F A MIELKE
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1956

6.  Indian Rauwolfia research led to the evolution of neuropsychopharmacology & the 2000 Nobel Prize (Part I).

Authors:  Prakash N Tandon
Journal:  Indian J Med Res       Date:  2021-07       Impact factor: 2.375

7.  Indian Rauwolfia research led to the evolution of neuropsychopharmacology & the 2000 Nobel Prize (Part II).

Authors:  Prakash N Tandon
Journal:  Indian J Med Res       Date:  2021-07       Impact factor: 2.375

Review 8.  Parkinson's disease, dopaminergic drugs and the plant world.

Authors:  Peter Kempster; Andrew Ma
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.